Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Smith & Nephew Snats ADR (NY: SNN )

25.15 -0.16 (-0.63%)
Official Closing Price Updated: 4:10 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Smith & Nephew Snats ADR

< Previous 1 2 3 Next >
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew raises the bar in knee revisions by launching new LEGION™ Hinged Knee System with OXINIUM™ Technology
From Smith & Nephew UK Ltd
Via GlobeNewswire
First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility
From Smith & Nephew UK Ltd
Via GlobeNewswire
3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications
From 3D Systems Inc.
Via GlobeNewswire
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
From Smith & Nephew UK Ltd
Via GlobeNewswire
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
From AVITA Medical
Via GlobeNewswire
Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers
From Smith & Nephew UK Ltd
Via GlobeNewswire
Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board
From Smith & Nephew UK Ltd
Via GlobeNewswire
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family 
Via Benzinga
Macy's, Koss And Other Big Stocks Moving Higher On Friday
Via Benzinga
Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge
Smith & Nephew shares rise as Cevian Capital acquires a 5% stake, aiming to improve operational performance. The medical tech firm faces challenges with declining market cap and mixed revenue growth. 
Via Benzinga
Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System
From Smith & Nephew UK Ltd
Via GlobeNewswire
4 Stocks to Watch in the Booming Regenerative Medicine Market
Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than... 
Via TheNewswire.com
4 Stocks to Watch in the Booming Regenerative Medicine Market
4 Stocks to Watch in the Booming Regenerative Medicine Market 
Via News Direct
Current Analysis: Smith & Nephew
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Over the past year, SNN's share price fell about 9.4% from... 
Via Talk Markets
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
From Smith & Nephew UK Ltd
Via GlobeNewswire
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033. 
Via InvestorPlace
British MedTech Firm Smith & Nephew Seeks To Adopt US-Inspired Pay Policy to Navigate Shareholder Skepticism
Smith & Nephew shakes up executive pay structure, aligning with US standards to curb turnover. Chairman Rupert Soames addresses global talent recruitment challenges and the shift's significance in the... 
Via Benzinga
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
From Smith & Nephew UK Ltd
Via GlobeNewswire
3 Millionaire-Maker Robotics Stocks to Buy in February 2024
Jump into the future with top robotics stocks poised for explosive growth. Discover the potential for massive returns. 
Via InvestorPlace
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
From Smith & Nephew UK Ltd
Via GlobeNewswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.